On 4 February the Gabinete Técnico Farmacéutico M. Camps and consultancy Azierta organise the webinar "Vigilance and post-marketing of medical devices".
This training, which will be held online for registered users -attendance is free of charge, subject to registration- will provide an overview of regulation and the steps to be taken to carry out PS monitoring.
The market surveillance and monitoring are an essential part of the marketing of medical devices.This is a sector in continuous innovation and of great importance in the European and Spanish market.
The webinar will be moderated by:
- Mercè Camps. CEO and founder of the Technical Pharmaceutical Cabinet MCamps
- Olegario Cuevas. Healthcare Business Manager at Azierta
The webinar presentation will be conducted by:
- Silvia de Andrés. Medical Devices Officer
- Alberto Orós. Technical Consultant
Surveillance and marketing of medical devices:
webinar programme
-
-
- Introduction
- Surveillance system
- Incident management
- Security corrective actions (FSCA) and security notices (FSN)
- Trend reporting
- Post-market surveillance system
- Periodic Security Update Report (PSUR)
- Post Market Monitoring Report (PMSR)
- Post-marketing clinical follow-up
-
Latest articles in our blog
GTF signs a collaboration agreement with Aquimisa
On Monday 4th July, Mercè Camps, director of Gabinete Técnico Farmacéutico M. Camps, signed a collaboration agreement with David Molinero, manager of Aquimisa Pharma, a control laboratory for the pharmaceutical, cosmetic and medical devices sectors ....
New format for Rapex reports
New Rapex infographic. After more than a year of reporting on the European Rapid Alert System Rapex, we at GTF have decided to convert the report into an infographic. We hope you like the new format, here we leave you the first two reports, from the past...
Epsco approves new Medical Devices Regulation
On 17 June, the European Commission's Employment, Social Policy, Health and Consumer Affairs Council (Epsco) approved the new European regulations on medical devices and IVD (in vitro diagnostics). Although the date for the adoption of the new regulations was already known, it is...